Kim Michael Fox
#115,705
Most Influential Person Now
Kim Michael Fox's AcademicInfluence.com Rankings
Kim Michael Foxmedical Degrees
Medical
#1659
World Rank
#2022
Historical Rank
Cardiology
#133
World Rank
#136
Historical Rank
Kim Michael Foxphilosophy Degrees
Philosophy
#5013
World Rank
#7717
Historical Rank
Logic
#2364
World Rank
#3343
Historical Rank
Download Badge
Medical Philosophy
Kim Michael Fox's Degrees
- Doctorate Medicine Harvard University
Why Is Kim Michael Fox Influential?
(Suggest an Edit or Addition)Kim Michael Fox's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Universal definition of myocardial infarction. (2015) (2234)
- Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) (2003) (1992)
- Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial (2008) (1000)
- Resting heart rate in cardiovascular disease. (2007) (981)
- Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial (2008) (774)
- Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry (2012) (619)
- Antianginal and Antiischemic Effects of Ivabradine, an If Inhibitor, in Stable Angina: A Randomized, Double-Blind, Multicentered, Placebo-Controlled Trial (2003) (510)
- Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials (2006) (477)
- Gender Differences in the Management and Clinical Outcome of Stable Angina (2006) (460)
- Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. (2006) (406)
- Ivabradine in stable coronary artery disease without clinical heart failure. (2014) (395)
- Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. (1982) (391)
- Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158 998 patients (2012) (386)
- CIRCADIAN VARIATION OF TOTAL ISCHAEMIC BURDEN AND ITS ALTERATION WITH ANTI-ANGINAL AGENTS (1988) (340)
- Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study (2016) (332)
- Chest pain in women: clinical, investigative, and prognostic features (1994) (307)
- Myocardial bridges: morphological and functional aspects. (1991) (299)
- DIMENSIONAL ACCURACY OF MAGNETIC RESONANCE IN STUDIES OF THE HEART (1985) (278)
- Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. (2006) (264)
- Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. (1998) (227)
- Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group. (1996) (226)
- Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. (2009) (213)
- Predicting prognosis in stable angina—results from the Euro heart survey of stable angina: prospective observational study (2006) (198)
- Ticagrelor in Patients with Stable Coronary Disease and Diabetes. (2019) (198)
- Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial (2011) (197)
- Morphology of ambulatory ST segment changes in patients with varying severity of coronary artery disease. Investigation of the frequency of nocturnal ischaemia and coronary spasm. (1985) (191)
- Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) (181)
- The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group. (1996) (160)
- Antianginal Efficacy and Safety of Ivabradine Compared with Amlodipine in Patients with Stable Effort Angina Pectoris (2012) (155)
- ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. (2007) (152)
- The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy. (2005) (137)
- Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina. (1994) (134)
- Cardioprotection by opening of the KATPchannel in unstable anginaIs this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil (1999) (131)
- The Effects of Nifedipine on Acute Experimental Myocardial Ischemia and Infarction in Dogs (1979) (128)
- Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease. (1999) (121)
- MECHANISMS OF NOCTURNAL ANGINA PECTORIS: IMPORTANCE OF INCREASED MYOCARDIAL OXYGEN DEMAND IN PATIENTS WITH SEVERE CORONARY ARTERY DISEASE (1984) (118)
- Silent myocardial ischaemia in chronic stable angina: a study of its frequency and characteristics in 150 patients. (1988) (113)
- Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol. (1984) (113)
- Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. (1998) (112)
- The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA). (1998) (106)
- The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina. (2005) (104)
- Comparison of Doppler derived haemodynamic variables and simultaneous high fidelity pressure measurements in severe pulmonary hypertension. (1994) (97)
- Myocardial ischaemia in patients with frequent angina pectoris. (1978) (97)
- Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials. (2013) (96)
- Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram. (1996) (96)
- The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina. (2005) (95)
- A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis (2005) (95)
- Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial (2000) (95)
- Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty. (1988) (93)
- Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease (2012) (92)
- Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization. (1999) (90)
- Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate. (1987) (90)
- The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina (2005) (89)
- Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom. (1976) (87)
- Ambulatory electrocardiographic ST segment changes in healthy volunteers. (1983) (83)
- Patterns of Disturbed Myocardial Perfusion in Patients with Coronary Artery Disease: Regional Myocardial Perfusion in Angina Pectoris (1980) (82)
- Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. (2010) (81)
- Assessment of regional left ventricular function by magnetic resonance. (1986) (78)
- Cigarette smoking and the treatment of angina with propranolol, atenolol, and nifedipine. (1984) (78)
- Heart rate: a forgotten link in coronary artery disease? (2011) (75)
- Pulmonary artery pressure and activities in chronic heart failure (1990) (74)
- Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. (2003) (73)
- Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate‐lowering properties (2014) (71)
- Relation between the precordial projection of S-T segment changes after exercise and coronary angiographic findings. (1979) (71)
- The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina. (1989) (69)
- Hemoglobin Inhibits Endothelium‐Dependent Relaxation to Acetlcholine in Human Coronary Arteries In Vivo (1993) (69)
- Angina, “Normal” Coronary Angiography, and Vascular Dysfunction: Risk Assessment Strategies (2007) (69)
- Ischemia in the ambulatory setting--the total ischemic burden: relation to exercise testing and investigative and therapeutic implications. (1989) (67)
- How important is a history of chest pain in determining the degree of ischaemia in patients with angina pectoris? (1985) (66)
- Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. (2013) (66)
- The haemodynamic significance of asymptomatic ST segment depression assessed by ambulatory pulmonary artery pressure monitoring. (1986) (65)
- Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: Proposed revisions (2000) (64)
- Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study (2006) (64)
- The histology of viable and hibernating myocardium in relation to imaging characteristics. (2002) (62)
- The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. (2009) (62)
- Significance of exercise induced ST segment elevation in patients with previous myocardial infarction. (1983) (60)
- Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients (2014) (60)
- Heart rate reduction in coronary artery disease and heart failure (2016) (59)
- CMR Guidance for Recanalization of Coronary Chronic Total Occlusion. (2016) (59)
- Treatment of angina pectoris with nifedipine: importance of dose titration. (1983) (59)
- Objective assessment of treatment in severe angina. (1979) (58)
- Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study). (2007) (58)
- Diurnal variation of pulmonary artery pressure in chronic heart failure. (1989) (57)
- Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo. (1985) (57)
- Ischaemic cardiac events and use of strontium ranelate in postmenopausal osteoporosis: a nested case–control study in the CPRD (2013) (57)
- Inability of the ST segment/heart rate slope to predict accurately the severity of coronary artery disease. (1984) (57)
- The EUROPA Trial: Design, Baseline Demography and Status of the Substudies (2001) (56)
- Magnetic resonance assessment of aortic and mitral regurgitation. (1986) (56)
- The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina. (2006) (55)
- Hibernating myocardium: clinical and functional response to revascularisation. (1997) (53)
- The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial. (2007) (52)
- Insight into the Mode of Action of ACE Inhibition in Coronary Artery Disease (2012) (51)
- Long-term beta blockade: possible protection from myocardial infarction. (1975) (51)
- IMPORTANCE OF "RECIPROCAL" ELECTROCARDIOGRAPHIC CHANGES DURING OCCLUSION OF LEFT ANTERIOR DESCENDING CORONARY ARTERY Studies during Percutaneous Transluminal Coronary Angioplasty (1986) (49)
- Coronary flow reserve in patients with chest pain and normal coronary arteries. (1993) (48)
- Nocturnal angina: precipitating factors in patients with coronary artery disease and those with variant angina. (1986) (48)
- ACE Inhibition and Endothelial Function: Main Findings of PERFECT, a Sub-Study of the EUROPA Trial (2007) (48)
- EFFECTS OF PLATELET INHIBITION ON MYOCARDIAL ISCHAEMIA (1981) (48)
- Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk. (2006) (48)
- Pathophysiology of angina (1990) (47)
- Heart rate and blood pressure consequences of an afternoon SIESTA (Snooze-Induced Excitation of Sympathetic Triggered Activity). (1993) (47)
- β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study (2019) (47)
- Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting. (2004) (47)
- A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals (2011) (47)
- Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry (2019) (46)
- Precordial electrocardiographic mapping after exercise in the diagnosis of coronary artery disease. (1979) (46)
- Impact of renin-angiotensin system inhibitors on mortality and major cardiovascular endpoints in hypertension: A number-needed-to-treat analysis. (2015) (45)
- Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study. (2015) (44)
- Initial experience with a physiological, rate responsive pacemaker. (1983) (44)
- Cardiac Rehabilitation to Improve Physical Functioning in Refractory Angina: A Pilot Study (2012) (43)
- Inadequate control of heart rate in patients with stable angina: results from the European Heart Survey (2010) (42)
- Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study. (2010) (42)
- Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and Hypertension (2018) (42)
- A method for praecordial surface mapping of the exercise electrocardiogram. (1978) (41)
- Heart rate: a risk factor for cardiac diseases and outcomes? Pathophysiology of cardiac diseases and the potential role of heart rate slowing. (2006) (41)
- Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease (2017) (40)
- Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery Disease. (2017) (40)
- The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis. (2003) (40)
- Carcinoma of the oesophagus with "swallow syncope". (1975) (40)
- Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators. (1991) (38)
- Natural history and evaluation of Q waves during acute myocardial infarction. (1978) (38)
- Circadian variation of heart rate is affected by environment: a study of continuous electrocardiographic monitoring in members of a symphony orchestra. (1990) (37)
- The endothelial nitric oxide synthase (Glu298Asp and –786T>C) gene polymorphisms are associated with coronary in-stent restenosis (2002) (37)
- Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) Investigators. (1998) (35)
- The relationship between posture, blood pressure and electrophysiological properties in patients with paroxysmal supraventricular tachycardia. (1978) (35)
- [Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris]. (2006) (35)
- ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: Pertinent (2007) (35)
- Krypton-81m in the physiologic assessment of coronary arterial stenosis in man. (1979) (34)
- Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy). (2011) (34)
- Simultaneous assessment of myocardial viability and function for the detection of hibernating myocardium using ECG-gated 99Tcm-tetrofosmin emission tomography: a comparison with 201Tl emission tomography combined with cine magnetic resonance imaging. (1999) (34)
- Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure. (1990) (33)
- Value of the bipolar lead CM5 in electrocardiography. (1986) (33)
- Diurnal variation in left ventricular function: a study of patients with myocardial ischaemia, syndrome X, and of normal controls. (1987) (33)
- Haemodynamic response to myocardial ischaemia during unrestricted activity, exercise testing, and atrial pacing assessed by ambulatory pulmonary artery pressure monitoring. (1986) (33)
- Syndrome X: the haemodynamic significance of ST segment depression. (1986) (33)
- Electrocardiographic precordial mapping in anterior myocardial infarction. The critical period for interventions as exemplified by methylprednisolone. (1978) (32)
- Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease. (2019) (32)
- Interaction between cigarettes and propranolol in treatment of angina pectoris. (1980) (32)
- Plasma lysosomal enzyme activity in acute myocardial infarction. (1978) (32)
- Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease. (2013) (31)
- Should we get up in the morning? Observations on circadian variations in cardiac events. (1991) (31)
- Inability of exercise-induced R wave changes to predict coronary artery disease. (1982) (30)
- Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial (2020) (30)
- Secondary Prevention of Coronary Disease with ACE Inhibition-does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA? (2009) (30)
- Circadian patterns of myocardial ischemia. (1989) (29)
- Factors influencing R wave amplitude in patients with ischaemic heart disease. (1983) (29)
- Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry. (2014) (29)
- 64-multislice computed tomography in consecutive patients with suspected or proven coronary artery disease: initial single center experience. (2007) (29)
- Characterization and identification of women with angina pectoris. (1996) (29)
- Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke (2014) (29)
- Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor–Based Regimens: An Individual Patient Data Meta-Analysis From Randomized, Placebo-Controlled Trials (2010) (28)
- Comparison of the ST/heart rate slope with the modified Bruce exercise test in the detection of coronary artery disease. (1986) (28)
- Myocardial infarction in the dog: effects of intravenous propranolol. (1980) (28)
- Efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery disease. (2007) (28)
- Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery (2013) (27)
- Intracardiac electrode detection of early ischaemia in man. (1983) (27)
- Cardiovascular anomalies in thoracopagus twins and the importance of preoperative cardiac evaluation. (1977) (26)
- Calcium antagonists for cardiovascular disease (1989) (25)
- Impact of nicorandil in angina: subgroup analyses (2004) (25)
- Multiple and single ventricular septal defect. A clinical and haemodynamic comparison. (1978) (25)
- Projection of ST segment changes on to the front of the chest. Practical implications for exercise testing and ambulatory monitoring. (1982) (25)
- Tricuspid atresia. Clinical course in 62 cases (1967--1974). (1978) (25)
- Value of ambulatory ST segment monitoring in patients with chronic stable angina: does measurement of the "total ischaemic burden" assist with management? (1992) (24)
- Silent myocardial ischaemia in patients referred for coronary bypass surgery because of angina: a comparison with patients whose symptoms were well controlled on medical treatment. (1989) (24)
- Positive labeling of ischemic myocardium: A new approach in patients with coronary disease (1981) (24)
- ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT study. (2009) (24)
- The effects of intracoronary substance P and acetylcholine on coronary blood flow in patients with idiopathic dilated cardiomyopathy. (1994) (24)
- Impact of Chronic Kidney Disease on Use of Evidence-Based Therapy in Stable Coronary Artery Disease: A Prospective Analysis of 22,272 Patients (2014) (24)
- Lysosomal and Cytosolic Enzyme Release in Acute Myocardial Infarction: Effects of Methylprednisolone (1979) (24)
- Exercise heart rate/ST segment relation. Perfect predictor of coronary disease. (1982) (23)
- Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence? (2000) (22)
- Can we remove scar and fibrosis from adult human myocardium? (2018) (22)
- Continuous ambulatory pulmonary artery pressure monitoring. A new method using a transducer tipped catheter and a simple recording system. (1986) (22)
- Atenolol or nicardipine alone is as efficacious in stable angina as their combination: a double blind randomised trial. (1993) (22)
- Prognostic significance of acute systolic hypertension after myocardial infarction. (1975) (21)
- Variable susceptibility to dynamic coronary obstruction: an elusive link between coronary atherosclerosis and angina pectoris. (1983) (21)
- The influence of psychological factors and an early hospital follow-up on return to work after first myocardial infarction. (1975) (21)
- Ambulatory blood pressure monitoring and circadian variation of cardiovascular disease; clinical and research applications. (1992) (21)
- Antianginal and anti-ischaemic efficacy of tedisamil, a potassium channel blocker (2000) (21)
- Incidence of spasm at the site of previous successful transluminal coronary angioplasty: effect of ergometrine maleate in consecutive patients. (1986) (21)
- Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function. (2007) (20)
- Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis. (2015) (20)
- Cardiovascular Diseases in Europe Euro Heart Survey and National Registries of Cardiovascular Diseases and Patient Management (2006) (20)
- Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry (2018) (20)
- Relation between atrioventricular pathways and ventricular response during atrial fibrillation and flutter. (1981) (20)
- Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study (2019) (20)
- Safety and effectiveness of a portable external automatic defibrillator‐pacemaker (1983) (20)
- The effect of acute regional myocardial ischemia on the angiographic anatomy of coronary arteries. (1979) (20)
- Potassium channel openers in myocardial ischaemia: therapeutic potential of nicorandil. (2001) (20)
- Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunction. (2015) (20)
- Long term follow up of severely ill patients who underwent urgent cardiac transplantation. (1993) (20)
- Are there gender differences in patients presenting with unstable angina? (2000) (20)
- Management of refractory angina: an update. (2020) (19)
- Determinants of coronary events in patients with stable angina: results from the impact of nicorandil in angina study. (2005) (19)
- ORBITA revisited: what it really means and what it does not? (2018) (19)
- The Intracranial-B2LEED3S Score and the Risk of Intracranial Hemorrhage in Ischemic Stroke Patients Under Antiplatelet Treatment (2017) (18)
- Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function? (2006) (18)
- Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventric (2006) (18)
- Ultrasound-guided compression of femoral pseudoaneurysm: an audit of practice. (1998) (18)
- The role of heart rate may differ according to pathophysiological setting: from SHIFT to SIGNIFY. (2015) (18)
- Acute effect of oestrogen replacement therapy on treadmill performance in postmenopausal women with coronary artery disease. (1995) (17)
- Living alone and cardiovascular disease outcomes (2019) (17)
- Long-Term Follow-Up of the First Patients to Undergo Transcatheter Alcohol Septal Ablation (2010) (17)
- Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trial (2007) (17)
- Magnetic Resonance Imaging for Identifying Hibernating Myocardium (1998) (17)
- Effects of myocardial revascularisation in patients with effort angina and those with effort and nocturnal angina. (1985) (17)
- Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease (2020) (16)
- Heart disease in Asians in Britain. (1988) (16)
- Do ACE inhibitors modulate atherosclerosis? (1997) (16)
- The use of propranolol and nifedipine in the medical management of angina pectoris (1981) (16)
- Potassium channel openers: Clinical applications in ischemic heart disease—Overview of clinical efficacy of nicorandil (1995) (16)
- EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease. (1998) (15)
- Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry (2015) (15)
- Pericardial complications of endocardial and epicardial pacing. (1981) (15)
- A new system for ambulatory pulmonary artery pressure recording (1992) (15)
- The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting. (2005) (15)
- Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity–Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life Substudy (2016) (15)
- From antianginal drugs to myocardial cytoprotective agents. (1995) (15)
- The pathogenesis of atheroma and the rationale for its treatment. (1992) (15)
- Effect of nitroglycerin on the electrical changes of early or subendocardial ischaemia evaluated by monophasic action potential recordings. (1984) (15)
- Labetalol in the treatment of stable exertional angina pectoris: a comparison with nifedipine. (1988) (14)
- Selective and specific If inhibition: new perspectives for the treatment of stable angina (2006) (14)
- Precordial exercise mapping: improved diagnosis of coronary artery disease. (1978) (14)
- Therapeutic rationale for the management of silent ischemia. (1990) (14)
- Primary ventricular fibrillation and resumption of work, sexual activity, and driving after first acute myocardial infarction. (1975) (14)
- Angina: Ivabradine for treatment of stable angina pectoris (2009) (13)
- Detection of arrhythmia: limited usefulness of patient activated recording devices. (1984) (13)
- Electrophysiological manifestations of non-penetrating cardiac trauma. (1980) (13)
- Coronary balloon angioplasty for elderly patients with severe angina. (1987) (13)
- Future perspectives of If inhibition in various cardiac conditions (2005) (13)
- CLINICAL MEASUREMENT OF SERUM C‐REACTIVE PROTEIN IN THE MONITORING AND DIFFERENTIAL DIAGNOSIS OF INFLAMMATORY DISEASES AND TISSUE NECROSIS AND IN THE RECOGNITION AND MANAGEMENT OF INTERCURRENT INFECTION (1982) (13)
- Projection of electrocardiographic signs in praecordial maps after exercise in patients with ischaemic heart disease. (1979) (13)
- Low voltage electrocardiogram after acute myocardial infarction. (1975) (12)
- Optical transmission of normal and atheromatous arterial wall: a spectral analysis. (1986) (12)
- Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke (2016) (12)
- Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model (2016) (12)
- Significance of exercise induced ST segment elevation in patients with previous myocardial infarction (1982) (12)
- Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background beta blocker. (1993) (12)
- The endothelial nitric oxide synthase ( Glu 298 Asp and – 786 T > C ) gene polymorphisms are associated with coronary in-stent restenosis (2002) (12)
- Unpredictable zero drift in intravascular micromanometer tipped catheters during long term pulmonary artery pressure recording: implications for catheter design. (1989) (12)
- Ivabradine — a selective and specific If inhibitor: efficacy and safety in stable angina (2003) (12)
- A randomized, double‐blind, placebo‐controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics (2019) (11)
- EUROPA substudies, confirmation of pathophysiological concepts (1998) (11)
- Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: A post-hoc analysis of the PERFORM study (2018) (11)
- Rational approach to the medical therapy of angina pectoris: the role of calcium antagonists. (1983) (11)
- Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease. (2020) (11)
- Hypoplastic and fibrotic sinus node associated with intractable tachycardia in a neonate. (1980) (11)
- Plasma lysosomal enzyme activity in acute myocardial infarction and the effects of drugs. (1980) (11)
- Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: Rationale and design of the FORECAST trial. (2019) (11)
- Scientific integrity: what a journal can and cannot do. (2020) (11)
- Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: proposed revisions. International Cardiology Forum. (2000) (11)
- Circadian patterns of myocardial ischaemia and the effects of antianginal drugs. (1991) (11)
- Unstable and stable angina. (1993) (11)
- Characteristics of silent and painful ischaemia during ambulatory monitoring in patients with coronary arterial disease. (1990) (11)
- Association between discharge heart rate and left ventricular adverse remodelling in ST segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention (2013) (11)
- Current roles and future possibilities for low-molecular-weight heparins in unstable angina. (1998) (10)
- The 2018 ESC-ESH guidelines for the management of arterial hypertension leave clinicians facing a dilemma in half of the patients. (2018) (10)
- Combined High-Dosage Administration of Nifedipine and Propranolol in Patients with Angina Pectoris (1980) (10)
- Clinical presentation and management of stable coronary artery disease: insights from the international prospective CLARIFY registry - results from the Greek national cohort. (2014) (10)
- Myocardial imaging with extractable cations and inert tracers: The effects of flow and metabolism (1978) (10)
- Magnetic resonance assessment of regional left ventricular function (1986) (10)
- Treatment of angina pectoris with nifedipine: a double blind comparison of nifedipine and slow-release nifedipine alone and in combination with atenolol. (1987) (9)
- Circadian rhythms in cardiovascular function. (1991) (9)
- Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trial. (2009) (9)
- International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina (2021) (9)
- Electrocardiographic mapping after exercise for evaluation of coronary bypass graft surgery. (1979) (9)
- Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials. (2021) (9)
- Management of coronary artery disease: implications of the EUROPA trial (2004) (9)
- Under-diagnosis of diabetes mellitus in patients with coronary artery disease. (2004) (9)
- Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - results from EUROPA. (2015) (8)
- An Investigation in Patients with Previous Myocardial Infarction Who Present with Chest Pain (1981) (8)
- Vasculitis masquerading as aortic valve endocarditis (2005) (8)
- Effects of amlodipine versus diltiazem on morning peak in myocardial ischemic activity in angina pectoris. (1993) (8)
- Is calcium the clue? (2002) (8)
- The effects of nisoldipine on the total ischaemic burden: the results of the ROCKET study. (1991) (8)
- Circadian Variation of the Total Ischemic Burden and Influence by β‐Blocking Agents (1990) (8)
- Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry (2019) (8)
- Coronary anatomy in patients with various manifestations of three vessel coronary artery disease. (1985) (8)
- Praecordial surface mapping after exercise in evaluation of propranolol for angina pectoris. (1980) (8)
- Double-blind randomised placebo-controlled dose-efficacy study of sustained release verapamil in chronic stable angina. (1991) (7)
- Silent ischaemia: clinical implications in 1988. (1988) (7)
- Heart rate and use of β-blockers in Mexican stable outpatients with coronary artery disease. (2015) (7)
- Factors influencing the treatment of chronic stable angina pectoris with nifedipine. (1983) (7)
- Early treatment of unstable angina. (1986) (7)
- Potassium channel openers in myocardial ischaemia - clinical experience with nicorandil (1999) (7)
- The incidence and morphology of ischaemic ventricular tachycardia. (1986) (7)
- The vicious circle ef ischemic left ventricular dysfunction (1995) (7)
- The effect of established beta-adrenoreceptor-blocking therapy on the release of cytosolic and lysosomal enzymes after acute myocardial infarction in man. (1978) (7)
- Current status: heart rate as a treatable risk factor (2011) (7)
- The dose-response effects of nifedipine of ST-segment changes in exercise testing: preliminary studies. (1981) (6)
- The haemodynamic response to myocardial ischaemia in ambulant patients with variant angina. (1986) (6)
- Quality of haemofiltration fluids: a potential cause of severe electrolyte imbalance. (1987) (6)
- Acute blood pressure reduction causes left ventricular functional impairment in hypertensive patients with coronary heart disease and left ventricular hypertrophy (1991) (6)
- Effects of nifedipine on creatine kinase release during myocardial ischemia in dogs. (1978) (5)
- Myocardial infarction and the normal coronary arteriogram. (1983) (5)
- Magnetic resonance quantification of atrial shunting and valvular regurgitation (1986) (5)
- Follow up in a case of cardiac contusion using cardiovascular magnetic resonance. (2007) (5)
- b -blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study (2018) (5)
- The effects of propranolol on myocardial perfusion and metabolism during acute regional ischaemia (1978) (5)
- Heart rate and B-blockade in stable coronary artery disease in Greece. (2015) (5)
- The interaction of cigarette smoking and beta-adrenoceptor blockade. (1984) (5)
- Perforation thresholds and safety factors in in vivo coronary laser angioplasty. (1988) (5)
- Contribution of perindopril to cardiology: 20 years of success (2007) (5)
- Contribution of perindopril to cardiology : 20 years of success (2007) (5)
- IMPROVING OUTCOME AFTER ACUTE MYOCARDIAL INFARCTION: WHAT IS THE ROLE OF ACE INHIBITORS? (1995) (5)
- Therapeutic implications of dynamic coronary stenosis in patients with single vessel coronary artery disease. (1991) (5)
- Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease. (2021) (5)
- Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities. (2021) (5)
- Maximal oxygen uptake in severe aortic regurgitation: a different view of left ventricular function. (1990) (5)
- Potassium Channel Openers in Myocardial Ischaemia (2012) (5)
- Clinical Validation of Left and Right Ventricular Stroke Volumes Determined by Magnetic Resonance Imaging (1985) (5)
- Quality of life with ivabradine in patients with angina pectoris: The SIGNIFY Quality of Life substudy (2015) (5)
- The influence of right heart catheterisation on pulmonary arterial pressure in chronic heart failure: relationship to neuroendocrinal changes. (1991) (4)
- Treatment of angina pectoris with propranolol: the harmful effects of cigarette smoking. (1981) (4)
- Simple risk models to predict cardiovascular death in patients with stable coronary artery disease (2020) (4)
- Effect of an α2 agonist (mivazerol) on limiting myocardial ischaemia in stable angina (1999) (4)
- Precordial electrocardiographic mapping in the identification of patients with left main stem narrowing. (1983) (4)
- Effects of Increasing Doses of Nifedipine in Exertional Angina (1981) (4)
- Heart Rate Management in Stable Angina (2005) (4)
- C-Reactive Protein in Myocardial Infarction and Ischaemia (1982) (4)
- Safe amounts of contrast medium for angiocardiography in neonates and infants. (1977) (4)
- Precordial surface mapping of the exercise ECG. (1982) (4)
- Assessment of coronary venous bypass graft function using krypton-81m. (1979) (4)
- Nitrates in silent ischemia (1994) (3)
- The Effect of Long-Acting Nitrates on Ambulatory ECG Changes in Patients with Angina Pectoris Treated for 1 Week (1983) (3)
- Endothelium dependent and independent responses in coronary artery disease measured at angioplasty. (1993) (3)
- Factors influencing the resumption of work, sexual activity, and driving following acute myocardial infarction (1977) (3)
- Loss of electrically active myocardium during inferior infarction in man. (1978) (3)
- Praecordial Electrocardiographic Mapping after Exercise in the Diagnosis of Coronary Artery Disease (1979) (3)
- Management of unstable angina : an evolving field : proceedings of a symposium held at the XIXth Congress of the European Society of Cardiology, Stockholm, Sweden, August 1997 (1998) (3)
- Improving outcome in acute coronary syndromes - as good as it gets? (1999) (3)
- Evidence That Myocardial Potassium Loss during Ischaemia in Man Precedes Electrocardiographic Changes and Chest Pain (1983) (3)
- Identification of hibernating myocardium: A comparison of TI-201, Tc-99m tetrofosmin, and dobutamine cine magnetic resonance imaging (1996) (3)
- Diagnosis of broad complex tachycardias with ambulatory monitoring of atrial electrography. (1984) (3)
- Serial changes in high-sensitivity cardiac troponin, N-terminal pro-B-type natriuretic peptide, and heart fatty acid binding protein during exercise echocardiography in patients with suspected angina pectoris and normal resting left ventricular function. (2015) (2)
- Ivabradine — a selective and specific I f inhibitor : efficacy and safety in stable angina (2004) (2)
- Precordial mapping of ST-segment elevation and Q waves following anterior myocardial infarction. The effects of established beta-blocking drugs. (1979) (2)
- Poststroke patients: implications for the cardiologist (2003) (2)
- 'Bradycardia-tachycardia' syndrome 8 yr after correction of Fallot's tetralogy. (1979) (2)
- The use of an implantable left ventricular assist device in a patient with cardiogenic shock following acute myocardial infarction. (1998) (2)
- The clinical application of ACE inhibitors in coronary artery disease (2002) (2)
- Pharmacotherapy: Xanthine oxidase inhibition for relief of angina pectoris (2010) (2)
- Instability of “Stable Angina Pectoris” (1982) (2)
- Medical treatmentofpatients withsevere exertional andrestangina: double blind comparison of,B blocker, calcium antagonist, andnitrate (1987) (2)
- Angina Pectoris and Myocardial Ischemia in Coronary Disease (1981) (2)
- Prevalence, Incidence and Prognostic Implications of Left Bundle Branch Block in Patients with Chronic Coronary Syndromes (From the CLARIFY Registry). (2021) (2)
- Abstract 5066: The Treatment Effect of Perindopril is Consistent in All Patients with Vascular Disease or High Risk of Vascular Disease: A Combined Analysis of Three Perindopril Trials (2008) (2)
- Specificities of Ischemic Stroke Risk Factors in Arab-Speaking Countries (2017) (2)
- Benefits of perindopril all along the cardiovascular continuum: the level of evidence† (2008) (2)
- Effect of acadesine, a new metabolic agent, on exercise-induced myocardial ischemia in chronic stable angina (1994) (2)
- Ivabradine: advantages throughout the cardiovascular continuum (2010) (2)
- Can we really justify the treatment of silent ischemia in 1992? No! (1992) (2)
- Elevated heart rate proven to increase coronary events. (2008) (2)
- The management of hypercholesterolaemia in patients with coronary artery disease referred for coronary angiography. (1998) (2)
- Coronary artery disease and ACE inhibitors : from rationale to clinically proven benefits (2000) (2)
- A colour atlas of physical signs in cardiovascular disease (1989) (2)
- The vicious circle of ischemic left ventricular dysfunction. (1995) (2)
- Investigation of the mechanisms and consequences of transient myocardial ischaemia. (2009) (2)
- Reuse of devices in cardiology. (1999) (2)
- Disturbances of Regional Myocardial Perfusion and Praecordial ECG Signs in Patients with Coronary Artery Disease (1979) (2)
- Exercise testing in the diagnosis of ischaemic heart disease. (1982) (1)
- Laser assisted coronary angioplasty. (1988) (1)
- The effects of an antiplatelet drug on myocardial ischemia in patients with coronary artery diseasc (1980) (1)
- Abstract 3781: Long-Term Effect of Perindopril on Coronary Atherosclerosis Progression: Results from the Multicenter, Randomized PERindopril's Prospective Effect on Coronary aTherosclerosis by Angiography and IntraVascular Ultrasound Evaluation (PERSPECTIVE) Study, an EUROPA Substudy (2006) (1)
- Diltiazem: a new calcium antagonist for the treatment of chronic stable angina. (1983) (1)
- Can calcium antagonists reverse atherosclerosis? (1999) (1)
- POTASSIUM CHANNEL ACTIVATORS IN THE MANAGEMENT OF ISCHAEMIC HEART DISEASE: A FOCUS ON NICORANDIL (1993) (1)
- Thehaemodynamic significance ofasymptomatic ST segmentdepression assessed byambulatory pulmonary artery pressuremonitoring (1986) (1)
- Mechanism of the J-curve relationship between diastolic blood pressure and death from myocardial infarction in hypertensive patients with impaired coronary flow reserve (1990) (1)
- Editorial note Upsloping ST segment and R wave analysis in the diagnosis of coronary artery disease (1984) (1)
- N-T Pro-BNP is a powerful predictor of outcome in patients with stable angina: A substudy of the IONA trial (2003) (1)
- Cost–effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial (2022) (1)
- Thehaemodynamic response tomyocardial ischaemia inambulant patients withvariant angina (1986) (1)
- Choice of therapy in chronic ischemic heart disease. (1987) (1)
- The Role of Ambulatory St Segment Monitoring in Clinical Practice (1985) (1)
- Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY Registry (2020) (1)
- Clinical trials in silent ischaemia: lessons from TIBET. (1993) (1)
- Response to the commentary from Bisbal et al., titled 'Adipose graft transposition procedure: towards a novel strategy for myocardial scar and fibrosis reduction'. (2019) (1)
- Effect ofpartial agonistactivity inf3blockers insevere angina pectoris: a doubleblindcomparison ofpindolol andatenolol (1984) (1)
- The neurohumoral response to exercise in coronary heart disease and the relationship with inducible ischemia (2003) (1)
- Should we treat silent ischaemia (1987) (1)
- Balance of Benefit and Risk of Ticagrelor in Patients With Diabetes and Stable Coronary Artery Disease According to Bleeding Risk Assessment With the CRUSADE Score: Data From THEMIS and THEMIS PCI: Abbreviated title: Bleeding risk stratification of ticagrelor. (2022) (1)
- Labetalol in normotensive patients with angina pectoris (1988) (1)
- Myocardial ischemia and angina pectoris: the clinical problem in patients. (1981) (1)
- How European cardiologists perceive the role of calcium antagonists in the treatment of stable angina. (1997) (1)
- Angina due to high heart rate (2019) (1)
- The Diagnostic Potential of Telephone Transmission of the Electrocardiogram in Patients with Rhythm Disturbances and Chest Pain (1981) (1)
- Gated Tc-99m-tetrofosmin spect in the identification of myocardial hibernation: Comparison with T1-201 spect and cine MRI (1997) (1)
- Clinical Exploitation of the KATP Channel (1995) (1)
- Age and gender bias at multiple levels in the investigation and management of stable angina: findings from the Euro Heart Survey of newly presenting stable angina (2004) (1)
- DRUGS IN FOCUS : NICORANDIL (1999) (1)
- Effect of an alpha(2) agonist (mivazerol) on limiting myocardial ischaemia in stable angina. (1999) (1)
- The changing horizon of acute coronary syndrome (2009) (1)
- Editorial note Exercise testing after myocardial infarction (1985) (1)
- Low frequency oscillations in pulmonary arterial pressure in chronic heart failure. (1993) (1)
- Indication and clinical significance of exercise surface mapping (1979) (1)
- The Natural History and an Evaluation of ST Segment Changes and Release of MB-Creatine Kinase Activity in Acute Myocardial Infarction (1977) (1)
- ECG CHANGES DURING SELECTIVE PERCUTANEOUS TRANSLUMINAL CORONARY ARTERY ANGIOPLASTY (1986) (1)
- Use of risk score to identify lower and higher risk subsets among COMPASS-Eligible patients with stable CAD. Insights from the CLARIFY Registry (2020) (1)
- A colour atlas of palpitation & syncope (1989) (0)
- The role of nitrates on regional subendocardial ischaemia--studies with endocardial monophasic action potentials during pacing-induced angina. (1983) (0)
- Prediction of major coronary events in stable angina: The IONA study (2003) (0)
- Diagnosis — Methods for Evaluating Myocardial Microcirculation in Patients (1982) (0)
- Perforation thresholds andsafety factors ininvivo coronarylaser angioplasty (1988) (0)
- New results with ivabradine (2009) (0)
- Exercise test results in all women according to presence or absence of pain during test Chest pain No chest pain (0)
- FREQUENT and PROLONGED DISTURBANCES OF THE MYOCARDIUM IN PATIENTS WITH ANGINA PECTORIS (1982) (0)
- Exercise electrocardiography in coronary artery disease. (1987) (0)
- Clinical outcomes for patients with stable coronary disease in Australia - findings from the CLARIFY registry (2015) (0)
- The authors reply. (1987) (0)
- A colour atlas of palpitation (2012) (0)
- Rapid measurement of left ventricular volume from single oblique magnetic resonance images (1986) (0)
- Angina due to obstructive coronary artery disease with type 2 diabetes (2019) (0)
- A Colour Atlas of Palpitation and Syncope (2013) (0)
- Potential Value of Exercise Testing in Patients with Old Myocardial Infarction (1980) (0)
- Editorial Silent ischaemia: clinical implications in 1988 (2005) (0)
- The influence of right heart catheterisation on pulmonary pressure in chronic heart failure: relationship to neuroendocrinal changes arterial (1991) (0)
- The Relevance of Silent Ischaemia for the Clinician (1987) (0)
- Treating silent ischemia (1990) (0)
- Early intervention in acute coronary syndrome: is bivalirudin monotherapy an effective antithrombotic strategy? (2008) (0)
- THE IMPACT OF CHRONIC KIDNEY DISEASE ON USE OF EVIDENCE BASED THERAPY IN STABLE CORONARY ARTERY DISEASE: A PROSPECTIVE ANALYSIS OF 22,560 PATIENTS (2013) (0)
- The Reply. (2018) (0)
- Hotline at the European Society of Cardiology: what questions will these multicentric trials answer? (1991) (0)
- Altered determinants and circadian variation of transient myocardial ischemia in unstable angina and non-Q wave MI (1996) (0)
- Ischaemic heart disease (1986) (0)
- Ace inhibition with perindopril and markers of atherosclerosis and thrombosis: Results of the pertinent study (2007) (0)
- Ischaemic heart disease Overview (1987) (0)
- Myocardial Blood Flow, Ischaemia and Malignant Arrhythmias (1979) (0)
- The Influence of Cigarette Smoking on the Medical Management of Angina (1983) (0)
- TheCritical Period forInterventions asExemplified byMethylprednisolone (1978) (0)
- Lack of rebound during intermittent transdermal (0)
- The vicious Circle of lschemic Wt Ventricular Dysfunction (1995) (0)
- Inability oftheSTsegment/heart rateslope to predict accurately theseverityofcoronaryartery disease (1984) (0)
- The haemodynamic response to ST segment changes during coronary arteriography. (1990) (0)
- Angina due to hypertension and dyslipidaemia (2019) (0)
- Electrocardiographic Mapping after Exercise in the Evaluation of the Use of Propranolol for Angina Pectoris (1979) (0)
- PREVALENCE AND IMPACT OF ANGINA IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE AND DIABETES. INSIGHTS FROM THE THEMIS TRIAL (2023) (0)
- Haemodynamic changes during silent myocardial ischaemia. (1987) (0)
- Letter: Beta-blockade and myocardial infarction. (1975) (0)
- P18. Effects of antianginal drugs on platelet function (1996) (0)
- Silent ischaemia : clinical implications in 1988 365 (0)
- Ischemic St-Segment Depression in Ambulatory Patients. the Importance of Frequency and Variability (1982) (0)
- Use of risk scores to identify lower and higher risk subsets among COMPASS‐eligible patients with chronic coronary syndromes. Insights from the CLARIFY registry (2020) (0)
- Abstract 2456: Strong and Independent Association between Angiotensinogen Gene Polymorphisms and Hypertension in 10060 Patients with Stable Coronary Artery Disease (2008) (0)
- Electrocardiographic Precordial Mapping in Anterior Myocardial Infarction (1978) (0)
- Experimental Studies: The Appearance of Large Coronary Arteries during Arteriography (1980) (0)
- Repeated Heart Rate Measurement and Cardiovascular Outcomes in LVSD (2015) (0)
- Exercise and Myocardial Ischemia in Patients with Angina Pectoris (1982) (0)
- Effect of Nifedipine on Echocardiographic Indices of Left Ventricular Function and Regional Myocardial Perfusion of the Normal and Ischaemic Dog Heart (1978) (0)
- Perspectives in cardiology 1984 (1984) (0)
- PREVENTION OF CARDIAC EVENTS IN CORONARY ARTERY DISEASE PATIENTS: S1 (2004) (0)
- Smoking, catecholamines, and the ischemic myocardium. (1988) (0)
- The changing face of unstable angina. (1999) (0)
- Precordial electrocardiographic mapping in the identification of patients with left main stem disease (1981) (0)
- 242 Cardiovascular Benefits Of Perindopril In Coronary Artery Disease Patients With Hypertension. New Findings From The Europa Study According Jnc-7 Definition Of Hypertension (2010) (0)
- Impact factor of the European Heart Journal. (2000) (0)
- The Effects of Regional Myocardial Function on the Appearance of Epicardial Vessels during Coronary Arteriography (1978) (0)
- Drugs for angina: how good? How safe? (1994) (0)
- Expanding the realm of cardiovascular therapy : proceedings from an official satellite symposium of the XIXth Congress of the European Society of Cardiology, Stockholm, Sweden, 27 August 1997 (1999) (0)
- Prevention of Stroke and major cardiovascular events with perindopril-based treatment: The PROGRESS trial (2008) (0)
- An Experimental Model for Angina Pectoris; the Dynamic Balance between Myocardial Perfusion and Metabolism Using Krypton-81 M (1978) (0)
- Issues in guidelines implementation : The International Cardiology Forum examines the new guidelines for UA/NSTEMI : workshop proceedings from the ICF 4th Annual International Experts' Meeting held in Budapest, Hungary in September 2000 (2001) (0)
- Clinical Presentation and Management of Outpatients with Stable Coronary Artery Disease—Australian Baseline Characteristics of the CLARIFY Registry (2012) (0)
- 80 Two Year Prognosis in Stable Coronary Artery Disease: A Prospective Study of 2346 Patients in UK Primary Care (2016) (0)
- Catheter Ablation of Cardiac Arrhythmias. A New System with Improved Safety and Efficacy (1986) (0)
- Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes. (2023) (0)
- 1 Subsequent Event Risk in Individuals with Established Coronary Heart Disease : Design and Rationale of the GENIUS-CHD Consortium Running title : (2019) (0)
- The NHLI at Imperial College, London. (2017) (0)
- Diltiazem comes in from the cold. (2001) (0)
- Systemic markers of inflammation do not predict coronary in-stent restenosis in stable angina patients treated with HMG CoA reductase inhibitors (2003) (0)
- continuom pulmonary artery pressure (2016) (0)
- The relationship between myocardial ischaemia and cell death during acute myocardial infarction. (1978) (0)
- Prevalence, incidence and prognostic implications of left bundle branch block in patients with stable coronary artery disease. An analysis from the CLARIFY registry (2020) (0)
- pain and normal coronary arteries . Coronary flow reserve in patients with chest (0)
- Abstract 12413: Haemoglobin and Change in Haemoglobin Status Predict Mortality, Cardiovascular Events and Bleeding in Stable Coronary Artery Disease: A Clarify Registry Analysis of 21,829 Patients From 45 Countries (2015) (0)
- The Role of Heart Rate Modulation for Care of Patients with Coronary Artery Disease and Heart Failure (2020) (0)
- Clinical perspectives on the management of advanced stable coronary disease (2012) (0)
- Gerneralizability of the REDUCE-IT trial in patients with stable coronary artery disease. An analysis from the CLARIFY registry (2019) (0)
- C-reactive protein in unstable angina: Lack of association with ischemic activity or complex lesion morphology (1996) (0)
- Diurnal variation inleft ventricular function: astudy ofpatients withmyocardial ischaemia, syndrome X, andofnormal controls (1987) (0)
- A survey of the investigation of new onset stable angina presenting to cardiology services in the UK, and how this compares the rest of Europe. The UK results of the Euro Heart Survey of Newly Presenting Angina (2004) (0)
- Intrinsic sympathomimetic activity in beta blockers the importance of basal heart rate reduction in the treatment of day time and nocturnal angina (1984) (0)
- Early continuous ECG monitoring predicts unfavorable short term outcome in patients admitted with unstable angina but not in acute myocardial infarction (1991) (0)
- Management of a patient with chronic stable angina (2019) (0)
- Therapeutic targets of antianginal and anti-ischaemic agents (1999) (0)
- The Inability of the ST Segment/Heart Rate Slope during Exercise Testing in Predicting the Severity of Coronary Artery Disease (1983) (0)
- Ambulatory Electrocardiographic S-T Segment Changes in Normal Volunteers (1983) (0)
- Avoidance oftolerance andlackofrebound with intermittent dosetitrated transdermal glyceryl trinitrate (1991) (0)
- Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smoking. (2020) (0)
- Should we treat silent ischaemic? (1987) (0)
- The Dose-Related Effects of Antianginal Drugs on Acute Regional Myocardial Ischaemia and Infarction (1978) (0)
- The treatment effects on circadian variation of transient myocardial ischemia (1989) (0)
- SNAPSHOT IN CARDIOLOGY (2019) (0)
- Silent myocardial ischaemia inchronic stable angina: astudy ofits frequency andcharacteristics in150 (1988) (0)
- THE INTRACRANIAL-B2LEED3S SCORE AND THE RISK OF INTRACRANIAL HEMORRHAGE IN ISCHAEMIC STROKE PATIENTS UNDER ANTIPLATELET TREATMENT (low Body mass index, Blood pressure, Lacune, Elderly, asian Ethnicity, cardiovascular Disease, cerebrovascular Disease, Dual antithrombotic treatment or anticoagulant, S (2016) (0)
- A colour atlas of adult congenital heart disease (1990) (0)
- Author’s Reply (2012) (0)
- and nocturnal angina . effort angina and those with effort revascularisation in patients with Effects of myocardial (0)
- Comparison of treadmill and bicycle ergometer exercise in middle-aged males. (1977) (0)
- Should We Treat Silent Ischaemia? (2012) (0)
- Amethod forpraecordial surface mapping ofthe exercise electrocardiogra m1 (1978) (0)
- The haemodynamic response to ST segment coronary arteriography (1990) (0)
- The endothelial nitric oxide synthase (eNOS) gene polymorphism (Glu298Asp) is associated with coronary in-stent restenosis (2002) (0)
- Combined clinical and pharmacogenetic risk scoring model determines ACE-inhibitor treatment benefit in patients with stable coronary artery disease (2013) (0)
- Silent Ischaemia: Pathophysiological, Prognostic and Therapeutic Indicators in Chronic Stable Angina (1991) (0)
- Prognostic implications of silent ischemia in patients with stable angina pectoris (1987) (0)
- A ONE‐YEAR MULTICENTRE STUDY OF SIMVASTATIN IN THE TREATMENT OF HYPERCHOLESTEROLEMIA (1994) (0)
- 4054Betablockers and outcomes in stable coronary artery disease. Insights from the CLARIFY registry (2018) (0)
- Myocardial Ischaemia in the Ambulatory Setting: A Comparative Study of Patients with Restrictive Angina and Those Well Controlled on Medical Therapy (1989) (0)
- Hemoglobin inhibits endothelium-dependent relaxation in human coronary arteries in vivo (1991) (0)
- An experimental model for angina pectoris using krypton-81m. The dynamic balance between myocardial perfusion and metabolism. (1979) (0)
- Diurnal variation ofpulmonary arterypressure in chronic heart failure (1989) (0)
- suMMARYPraecordial surface maps oftheelectrocardiogram (1979) (0)
- A Colour Atlas of Angina Pectoris (1986) (0)
- Can We Really Justify the Ischemia in 1992 ? No! Treatment of Silent (1992) (0)
- Low voltage electrocardiogram after acute myocardial infarction 749 (0)
- Diagnostic Electrocardiographic Tests: Dynamic, Isometric and Pacing (1985) (0)
- Diltazem comes in from the cold (2001) (0)
- ect of an á 2 agonist ( mivazerol ) on limiting myocardial ischaemia in stable angina (1999) (0)
- Abstract 10474: Cardiac Rehabilitation Improves Physical Functioning in Refractory Angina (2011) (0)
- Characteristics ofpatients studied Patient Age Before angioplasty After angioplasty Angina Exercise test Angioplasty Drug Angina Exercise test Ergometrine Exertion Rest duration (2005) (0)
- Mechanisms of Nocturnal Angina: Evaluation during Sleep (1984) (0)
- 403-P: Impact of Diabetes-Related Factors and Background Antihyperglycemic Therapy on the Efficacy and Safety of Ticagrelor Added to Aspirin: Insights from the THEMIS Trial (2020) (0)
- Transient myocardial ischemia relates to complex lesion morphology in refractory unstable angina more than the extent of coronary artery disease (1996) (0)
- Comparison of Coronary Anatomy in Patients with Rest and Effort Angina (1985) (0)
- Hypertension and the ischaemic myocardium. (1987) (0)
- The combined clinical and hemodynamic effects of trinitrin and propranolol. (1977) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Kim Michael Fox?
Kim Michael Fox is affiliated with the following schools:
